Evidence map›Paper›PMID 41133629›Full record

ReviewNeuroSci2025

Exploring the Efficacy of Cognitive Behavioral Therapy for Managing Anxiety in People with Parkinson's Disease.

Khaoula Elcadi, Raymond Klevor, Nissrine Louhab, Najib Kissani, Mohamed Chraa

Abstract readReview
In one paragraph

Review in NeuroSci, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Khaoula ElcadiClinical Experimental and Environmental Neuroscience Laboratory, Faculty of Medicine and Pharmacy of Marrakech, Cadi Ayaad University, Marrakech 40000, Morocco.ORCID 0009-0006-3153-9318
Raymond KlevorNeuroscience Research Laboratory, Faculty of Medicine and Pharmacy of Marrakesh, Cadi Ayaad University, Marrakech 40000, Morocco.ORCID 0000-0003-1346-1490
Nissrine LouhabDepartment of Neurology, Mohammed VI University Medical Center, Marrakesh 40000, Morocco.
Najib KissaniDepartment of Neurology, Mohammed VI University Medical Center, Marrakesh 40000, Morocco.
Mohamed ChraaDepartment of Neurology, Mohammed VI University Medical Center, Marrakesh 40000, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with Parkinson's disease frequently suffer from complicated anxiety disorders that are entwined with their attitudes and behaviors. In regard to this population, cognitive behavioral therapy (CBT) has been attracting an increasing amount of attention as a potentially effective treatment for mental health issues like anxiety. CBT helps patients manage stress and improve their psychological well being through behavioral, relaxation, and cognitive techniques. Even though there is already evidence that cognitive behavioral therapy (CBT) can dramatically reduce psychological symptoms in Parkinson's patients, more thorough research is required to determine its exact role in comprehensive anxiety treatment and prove its long-term efficacy. The purpose of this study is to examine the body of research on the use of cognitive behavioral therapy (CBT) to treat anxiety in patients with Parkinson's disease, looking at its limitations and challenges as well as clinical characteristics, advantages, and possible behavioral and psychological impacts.

Indexed as

anxietyCBTdepressionParkinson’s diseasepsychological health

Identifiers

PMID41133629
PMCPMC12551067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.